Hu, X., Zhang, Q., Sun, T., Xiong, H., Li, W., Teng, Y., Lu, Y., Tseng, L., Yan, M., Li, H., Pang, D., -Chen, S., Chen, W., Jiang, O., Wang, J., Wu, X., Wang, X., Zang, A., Wang, X., Collins, J. M., Fan, E., Jiang, L., Zeng, X., Turner, N. C. (2025). Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort. Nature Communications. https://doi.org/10.1038/s41467-025-59210-6